Page last updated: 2024-08-16

thalidomide and eicosapentaenoic acid

thalidomide has been researched along with eicosapentaenoic acid in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (28.57)	29.6817
2010's	4 (57.14)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Horrobin, DF	1
Tisdale, MJ	1
Contu, P; Dessì, M; Macciò, A; Madeddu, C; Mantovani, G; Massa, E; Panzone, F; Serpe, R	1
Mantovani, G	1
Bhargava, R; Chasen, M; Hirschman, S	1
Hariyanto, TI; Kurniawan, A	1

Reviews

3 review(s) available for thalidomide and eicosapentaenoic acid

Article	Year
Clinical anticachexia treatments. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2006, Volume: 21, Issue:2 Topics: Adipose Tissue; Adrenal Cortex Hormones; Cachexia; Eicosapentaenoic Acid; Energy Metabolism; Humans; Muscle, Skeletal; Progestins; Protein Biosynthesis; Thalidomide	2006
Immunomodulatory agents for the treatment of cachexia. Current opinion in supportive and palliative care, 2014, Volume: 8, Issue:4 Topics: Adipose Tissue; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Appetite; C-Reactive Protein; Cachexia; Cytokines; Eicosapentaenoic Acid; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Inflammation Mediators; Interferon-gamma; Muscular Atrophy; Neoplasms; Physical Therapy Modalities; Thalidomide; Tumor Necrosis Factor-alpha	2014
Appetite problem in cancer patients: Pathophysiology, diagnosis, and treatment. Cancer treatment and research communications, 2021, Volume: 27 Topics: Anorexia; Appetite; Clinical Trials, Phase III as Topic; Eicosapentaenoic Acid; Growth Differentiation Factor 15; Humans; Hydrazines; Mirtazapine; Neoplasms; Oligopeptides; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Thalidomide; Toll-Like Receptor 4; Treatment Outcome	2021

Trials

2 trial(s) available for thalidomide and eicosapentaenoic acid

Article	Year
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. The oncologist, 2010, Volume: 15, Issue:2 Topics: Appetite Stimulants; Cachexia; Carnitine; Eicosapentaenoic Acid; Female; Humans; Interleukin-6; Male; Medroxyprogesterone; Megestrol Acetate; Middle Aged; Neoplasms; Thalidomide; Vitamin B Complex	2010
Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia. European review for medical and pharmacological sciences, 2010, Volume: 14, Issue:4 Topics: Aged; Body Composition; Cachexia; Carnitine; Contraceptives, Oral, Hormonal; Eicosapentaenoic Acid; Endpoint Determination; Energy Metabolism; Female; Humans; Male; Medroxyprogesterone; Megestrol; Middle Aged; Motor Activity; Neoplasms; Prognosis; Thalidomide	2010

Article

Year

Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.

The oncologist, 2010, Volume: 15, Issue:2

Topics: Appetite Stimulants; Cachexia; Carnitine; Eicosapentaenoic Acid; Female; Humans; Interleukin-6; Male; Medroxyprogesterone; Megestrol Acetate; Middle Aged; Neoplasms; Thalidomide; Vitamin B Complex

2010

Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.

European review for medical and pharmacological sciences, 2010, Volume: 14, Issue:4

Topics: Aged; Body Composition; Cachexia; Carnitine; Contraceptives, Oral, Hormonal; Eicosapentaenoic Acid; Endpoint Determination; Energy Metabolism; Female; Humans; Male; Medroxyprogesterone; Megestrol; Middle Aged; Motor Activity; Neoplasms; Prognosis; Thalidomide

2010

Other Studies

2 other study(ies) available for thalidomide and eicosapentaenoic acid

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levels. Medical hypotheses, 2003, Volume: 60, Issue:5 Topics: Angiogenesis Inhibitors; Cell Cycle; Clotrimazole; Cyclin D1; Cyclooxygenase Inhibitors; Eicosapentaenoic Acid; Humans; Lymphoma, Mantle-Cell; Protein Biosynthesis; Thalidomide	2003

Article

Year

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chemical research in toxicology, 2010, Volume: 23, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010

A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levels.

Medical hypotheses, 2003, Volume: 60, Issue:5

Topics: Angiogenesis Inhibitors; Cell Cycle; Clotrimazole; Cyclin D1; Cyclooxygenase Inhibitors; Eicosapentaenoic Acid; Humans; Lymphoma, Mantle-Cell; Protein Biosynthesis; Thalidomide

2003